Webinar Technology

Characterizing the maternal immune environment during pregnancy: Implications for autism spectrum disorders

This webinar is brought to you by the Science/AAAS Custom Publishing Office

Characterizing the maternal immune environment during pregnancy: Implications for autism spectrum disorders

Recorded 07 December 2016


Under normal conditions, the maternal immune system is uniquely regulated during pregnancy to maintain a pathogen-free, yet noninflammatory environment for the developing fetus. However, factors such as cytokines and chemokines produced during gestation can have developmental consequences for the fetus. In particular, maternal immune dysregulation during pregnancy has been frequently associated with increased risk of autism spectrum disorders. This webinar will discuss the relationship between the maternal immune environment and autism risk, highlighting findings from the largest population-based prospective study to date to have examined the relationship between mid-gestational maternal cytokines and chemokines and risk for autism.

During the webinar, the viewers will:

  • Hear about recent research on the effects of in utero prenatal cytokine/chemokine levels
  • Gain insight into how to successfully integrate multiplexed assays into your research
  • Learn best practices for running multiplex protein detection assays to generate the best data.

This Webinar will last for approximately 60 minutes

Speaker bios

Karen Jones, Ph.D.

University of California, Davis
Davis, CA

Dr. Jones obtained her B.S. in psychology from The Ohio State University before earning her Ph.D. in interdisciplinary neuroscience from the University of Missouri. She continued her training at the University of California, Davis, where she is currently a postdoctoral fellow under the mentorship of Dr. Judy Van de Water. Dr. Jones’ primary research interest lies in understanding the etiology of autism spectrum disorders, with a special focus on how interactions between the nervous and immune systems during the perinatal period result in alterations to neurodevelopment relevant to autism. Her areas of expertise include animal modeling, neuroscience, and immunology.

Anthony Saporita, Ph.D.

St. Charles, MO

Dr. Saporita has over 10 years of experience in molecular biology and assay development. He earned his B.S. in biochemistry from the University of Missouri and his Ph.D. from Northwestern University. Before joining MilliporeSigma, he conducted postdoctoral research at Washington University in Saint Louis. As part of the R&D team at MilliporeSigma, Dr. Saporita designs new multiplex immunoassay panels for protein biomarker detection that are used in multiple research areas.

Sean Sanders, Ph.D.

Washington, DC

Dr. Sanders did his undergraduate training at the University of Cape Town, South Africa, and his Ph.D. at the University of Cambridge, UK, supported by the Wellcome Trust. Following postdoctoral training at the National Institutes of Health and Georgetown University, Dr. Sanders joined TranXenoGen, a startup biotechnology company in Massachusetts working on avian transgenics. Pursuing his parallel passion for writing and editing, Dr. Sanders joined BioTechniques as an editor, before joining Science/AAAS in 2006. Currently Dr. Sanders is the Senior Editor for Custom Publishing for the journal Science and Program Director for Outreach.

Sponsored by

Get webinar alerts

For more information on upcoming webinars, recorded sessions and more, sign up for webinar alerts.

Sign up here